SK29297A3 - Process for manufacture of pallidipin, a modified collagen-induced platelet inhibitor, a pharmaceutical composition, use, a recombinant vector - Google Patents

Process for manufacture of pallidipin, a modified collagen-induced platelet inhibitor, a pharmaceutical composition, use, a recombinant vector Download PDF

Info

Publication number
SK29297A3
SK29297A3 SK292-97A SK29297A SK29297A3 SK 29297 A3 SK29297 A3 SK 29297A3 SK 29297 A SK29297 A SK 29297A SK 29297 A3 SK29297 A3 SK 29297A3
Authority
SK
Slovakia
Prior art keywords
asp
pallidipin
pallidipine
protein
amino acid
Prior art date
Application number
SK292-97A
Other languages
English (en)
Slovak (sk)
Inventor
Christiane Noeske-Jungblut
Andreas Becker
Bernard Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK29297A3 publication Critical patent/SK29297A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK292-97A 1994-09-12 1995-09-11 Process for manufacture of pallidipin, a modified collagen-induced platelet inhibitor, a pharmaceutical composition, use, a recombinant vector SK29297A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12
PCT/EP1995/003573 WO1996008563A1 (fr) 1994-09-12 1995-09-11 Procede de preparation d'un inhibiteur modifie de l'agregation plaquettaire induite par le collagene: la pallidipine

Publications (1)

Publication Number Publication Date
SK29297A3 true SK29297A3 (en) 1997-10-08

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
SK292-97A SK29297A3 (en) 1994-09-12 1995-09-11 Process for manufacture of pallidipin, a modified collagen-induced platelet inhibitor, a pharmaceutical composition, use, a recombinant vector

Country Status (22)

Country Link
US (1) US5882887A (fr)
EP (1) EP0781334A1 (fr)
JP (1) JPH10505502A (fr)
CN (1) CN1075836C (fr)
AU (1) AU701643B2 (fr)
BG (1) BG63276B1 (fr)
BR (1) BR9508910A (fr)
CA (1) CA2199719A1 (fr)
CZ (1) CZ76297A3 (fr)
FI (1) FI971013A0 (fr)
HU (1) HU222398B1 (fr)
IL (1) IL115272A0 (fr)
MX (1) MX9701720A (fr)
NO (1) NO971110L (fr)
NZ (1) NZ293261A (fr)
PL (1) PL184617B1 (fr)
RO (1) RO117971B1 (fr)
RU (1) RU2186110C2 (fr)
SI (1) SI9520093A (fr)
SK (1) SK29297A3 (fr)
WO (1) WO1996008563A1 (fr)
ZA (1) ZA957649B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774107B1 (en) * 1999-03-18 2004-08-10 Merck Patent Gmbh Protein for blocking platelet adhesion
CA2578072A1 (fr) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions et procedes de traitement de la schizophrenie et de troubles associes
US7691839B2 (en) * 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
WO2012172427A2 (fr) * 2011-06-14 2012-12-20 National Taiwan University Composés peptidiques destinés à l'inhibition de l'agrégation plaquettaire
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
KR102063195B1 (ko) 2012-02-07 2020-01-07 글로벌 바이오 테라퓨틱스, 인크. 핵산 전달의 구획화된 방법 및 이의 조성물 및 용도
MX2015002994A (es) 2012-09-07 2016-01-14 Inserm Inst Nat De La Santé Et De La Rech Médicale Peptidos de inhibidores obtenidos del receptor desencadenante expresado en celulas mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos.
US11364032B2 (en) 2013-08-08 2022-06-21 Global Bio Therapeutics, Inc. Clamp device for minimally invasive procedures and uses thereof
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
CN118139655A (zh) 2021-08-13 2024-06-04 特里奥万斯控股公司 皮肤替代组合物及其产生和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0371041A1 (fr) * 1987-06-24 1990-06-06 Novo Nordisk A/S Procede de preparation d'une proteine ou d'un polypeptide, sequence d'adn codant pour le polypeptide, microorganisme contenant la sequence d'adn et le polypeptide et utilisation du polypeptide comme preparation pharmaceutique
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
AU672584B2 (en) * 1991-09-05 1996-10-10 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
HU222398B1 (hu) 2003-06-28
AU701643B2 (en) 1999-02-04
HUT76972A (hu) 1998-01-28
CA2199719A1 (fr) 1996-03-21
BR9508910A (pt) 1997-10-28
MX9701720A (es) 1997-06-28
PL319078A1 (en) 1997-07-21
US5882887A (en) 1999-03-16
CN1075836C (zh) 2001-12-05
AU3565795A (en) 1996-03-29
BG63276B1 (bg) 2001-08-31
SI9520093A (en) 1997-08-31
PL184617B1 (pl) 2002-11-29
NO971110L (no) 1997-05-07
FI971013A (fi) 1997-03-11
JPH10505502A (ja) 1998-06-02
CZ76297A3 (cs) 1998-01-14
NO971110D0 (no) 1997-03-11
WO1996008563A1 (fr) 1996-03-21
IL115272A0 (en) 1995-12-31
ZA957649B (en) 1996-04-15
FI971013A0 (fi) 1997-03-11
CN1159828A (zh) 1997-09-17
BG101226A (en) 1998-10-30
EP0781334A1 (fr) 1997-07-02
RU2186110C2 (ru) 2002-07-27
RO117971B1 (ro) 2002-11-29
NZ293261A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
JPS63503275A (ja) ファクター８：ｃの製造方法
JPH02121934A (ja) 組合せ医薬組成物
CZ384896A3 (en) NOVEL MUTANT PROTEINS hIL-4 AS ANTAGONISTS OR PARTIAL ANTAGONISTS OF HUMAN INTERLEUKIN 4
SK29297A3 (en) Process for manufacture of pallidipin, a modified collagen-induced platelet inhibitor, a pharmaceutical composition, use, a recombinant vector
EP0687731B1 (fr) Vecteur sécrétoire, microorganismes transformés contenant ledit vecteur et production d'un produit à partir dudit microorganisme
AU2005240096A1 (en) Human complement C3 derivates with cobra venom factor-like function
MXPA97001720A (en) Process for the manufacture of a modified palidipine, inhibitor of platelet aggregation induced by colag
KR100232683B1 (ko) 콜라겐에 의해 유도되는 혈소판 응집 억제제
JP2000505300A (ja) 組換えリボヌクレアーゼタンパク質
JPH10501813A (ja) 腫瘍処置のための組成物および方法
FI110669B (fi) Menetelmiä luonnosta eristettävissä tai synteettisesti valmistettavissa olevien trombiini-inhibiittorien valmistamiseksi
US5756454A (en) Collagen-induced platelet aggregation inhibitor
US5801017A (en) Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis
WO1993011778A1 (fr) Molecules anti-thrombotiques bifonctionnelles et polypetptides anti-trhombotiques